WSE:KME

Stock Analysis Report

Executive Summary

Kancelaria Medius S.A. engages in the receivables management business in Poland.

Rewards

Trading at 94.1% below its fair value

Risk Analysis

Interest payments are not well covered by earnings

Highly volatile share price over past 3 months

Profit margins (20.9%) are lower than last year (49.3%)

Does not have a meaningful market cap (PLN88M)



Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

Share Price & News

How has Kancelaria Medius's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: KME's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-6.2%

KME

0.3%

PL Commercial Services

1.1%

PL Market


1 Year Return

-39.5%

KME

10.7%

PL Commercial Services

-7.1%

PL Market

Return vs Industry: KME underperformed the Polish Commercial Services industry which returned 10.7% over the past year.

Return vs Market: KME underperformed the Polish Market which returned -7.1% over the past year.


Shareholder returns

KMEIndustryMarket
7 Day-6.2%0.3%1.1%
30 Day-6.2%-0.4%-3.1%
90 Day-13.6%6.5%-2.8%
1 Year-39.5%-39.5%11.3%10.7%-4.3%-7.1%
3 Year-24.3%-24.3%0.7%-4.5%5.8%-2.0%
5 Year314.5%303.3%22.3%18.0%3.3%-9.6%

Price Volatility Vs. Market

How volatile is Kancelaria Medius's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Kancelaria Medius undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: KME (PLN6.05) is trading below our estimate of fair value (PLN102.79)

Significantly Below Fair Value: KME is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: KME is poor value based on its PE Ratio (12.5x) compared to the Commercial Services industry average (11.3x).

PE vs Market: KME is poor value based on its PE Ratio (12.5x) compared to the Polish market (11x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate KME's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: KME is overvalued based on its PB Ratio (1.5x) compared to the PL Commercial Services industry average (1x).


Next Steps

Future Growth

How is Kancelaria Medius forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

16.5%

Forecasted Commercial Services industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kancelaria Medius has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Kancelaria Medius performed over the past 5 years?

32.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: KME has high quality earnings.

Growing Profit Margin: KME's current net profit margins (20.9%) are lower than last year (49.3%).


Past Earnings Growth Analysis

Earnings Trend: KME's earnings have grown significantly by 32.9% per year over the past 5 years.

Accelerating Growth: KME's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: KME had negative earnings growth (-69.9%) over the past year, making it difficult to compare to the Commercial Services industry average (-8.4%).


Return on Equity

High ROE: KME's Return on Equity (11.9%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Kancelaria Medius's financial position?


Financial Position Analysis

Short Term Liabilities: KME's short term assets (PLN159.9M) exceed its short term liabilities (PLN29.0M).

Long Term Liabilities: KME's short term assets (PLN159.9M) exceed its long term liabilities (PLN87.1M).


Debt to Equity History and Analysis

Debt Level: KME's debt to equity ratio (168.9%) is considered high.

Reducing Debt: KME's debt to equity ratio has increased from 129.2% to 168.9% over the past 5 years.

Debt Coverage: KME's debt is well covered by operating cash flow (21.7%).

Interest Coverage: KME's interest payments on its debt are not well covered by EBIT (2.8x coverage).


Balance Sheet

Inventory Level: KME has a low level of unsold assets or inventory.

Debt Coverage by Assets: KME's debt is covered by short term assets (assets are 1.6x debt).


Next Steps

Dividend

What is Kancelaria Medius's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.6%markettop25%7.2%industryaverage7.4%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate KME's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate KME's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if KME's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if KME's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of KME's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.


Next Steps

Management

What is the CEO of Kancelaria Medius's salary, the management and board of directors tenure and is there insider trading?


CEO

Michal Imiolek 0

0yrs

Tenure

0

Mr. Michal Imiolek serves as the President of the Management Board at Kancelaria Medius S.A. 


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Michal Imiolek

    President of the Management Board

    • Tenure: 0yrs

Board Members

  • Aleksander Szalecki

    Member of the Supervisory Board

    • Tenure: 0yrs
  • Artur Bienkowski

    Chairman of the Supervisory Board

    • Tenure: 0yrs
  • Marcin Rymaszewski

    Member of the Supervisory Board

    • Tenure: 0yrs
  • Przemyslaw Kowalewski

    Member of Supervisory Board

    • Tenure: 0yrs
  • Dominik Majewski

    Member of Supervisory Board

    • Tenure: 0yrs

Company Information

Kancelaria Medius S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Kancelaria Medius S.A.
  • Ticker: KME
  • Exchange: WSE
  • Founded:
  • Industry: Diversified Support Services
  • Sector: Commercial Services
  • Market Cap: zł88.221m
  • Shares outstanding: 14.58m
  • Website: https://www.kancelariamedius.pl

Location

  • Kancelaria Medius S.A.
  • ul. Babinskiego 69
  • Kraków
  • 30-393
  • Poland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KMEWSE (Warsaw Stock Exchange)YesCommon Bearer SharesPLPLNAug 2012

Biography

Kancelaria Medius S.A. engages in the receivables management business in Poland. It offers debt portfolios purchasing, debt collection management, and legal services, as well as manages claims secured by a ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/12/15 21:47
End of Day Share Price2019/12/13 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.